Osaic Holdings
AZN icon

Osaic Holdings’s AstraZeneca AZN Stock Holding History

Osaic Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.5K Buy
2
+1
+100% +$193 ﹤0.01% 6539
2025
Q4 		$5.51K Buy
+1
New +$175 ﹤0.01% 6659

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Osaic Holdings's AZN Position: Q1 2026 in Review

Osaic Holdings reduced its AstraZeneca (AZN) stake by 24% in Q1 2026, selling an estimated $4.25M and leaving 69,417 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #735.

Osaic Holdings first reported a position in AZN in Q1 2020 and has held it in 25 quarters since. The position peaked at $22.6M in Q3 2023. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Osaic Holdings held 69,417 shares of AstraZeneca worth $13.6M as of Q1 2026.
  • Osaic Holdings sold 22,026 AstraZeneca shares in Q1 2026, an estimated $4.25M.
  • AstraZeneca made up 0.02% of Osaic Holdings's portfolio in Q1 2026, its #735 holding.
  • Osaic Holdings first reported a position in AstraZeneca in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's AstraZeneca position peaked at $22.6M in Q3 2023.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.